J&J to buy Micrus Endovascular for deal valued at $480M

Justine Varieur Cadet | | Cardiovascular Business | Vascular & Endovascular
Image source: Chestnut Medical Technologies
Johnson & Johnson has signed a definitive agreement with Micrus Endovascular, a manufacturer of minimally invasive devices to address hemorrhagic and ischemic stroke, to be acquired in a cash-for-stock exchange.

Under the terms of the agreement, the San Jose, Calif.-based Micrus said its stockholders will receive at closing $23.40 for each outstanding share. The value of the transaction as of the anticipated closing date is estimated to be approximately $480 million, based upon Micrus Endovascular's 20.5 million fully diluted shares outstanding, according to the New Brunswick, N.J.-based J&J.

The boards of directors of J&J and Micrus have approved the transaction, which is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act, similar regulation in other countries, Micrus stockholder approval and other customary closing conditions.

Micrus will join Codman & Shurtleff, the neuro device business of the DePuy family of companies within J&J. Codman and Micrus offer technologies for treating cerebral aneurysms responsible for hemorrhagic stroke. The Codman neurovascular portfolio includes bare platinum coils, vascular reconstruction devices and access devices.

Justine Varieur Cadet

Related Content

IVUS-guided PCI reduces risks in patients with diabetes
LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Bioresorbable BTK stent superior to ballon angioplasty at 2 years
Shockwave Medical’s IVL technology delivers more positive outcomes for PAD patients
Standing desks fail to lower blood pressure or minimize heart risks—they may even do damage
IVL vs. RA for chronic total occlusion PCI: Key data cardiologists should know

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."